Anika Therapeutics Inc. (ANIK) vs Canopy Growth Corporation (CGC)

Anika Therapeutics Inc. and Canopy Growth Corporation are both Drug Manufacturers Specialty & Generic companies. Anika Therapeutics Inc. and Canopy Growth Corporation are of similar size ($283.5M and $258.7M). Canopy Growth Corporation grew revenue faster over the last twelve months: 7.80% against 5.33%. Anika Therapeutics Inc. has the higher net margin (−3.14% vs −80.4%) and the higher return on invested capital (−3.24% vs −17.2%). Across the 18 metrics below, Anika Therapeutics Inc. leads on 12 and Canopy Growth Corporation on 6.

Valuation

Metric ANIK CGC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 2.13 1.35 2.08
P/B 1.88 0.58 1.79
Price to free cash flow 458.01 n/m 16.29
EV/EBITDA 476.54 n/m 12.22
EV/Sales 2.02 1.01 2.87
Earnings yield (1.35%) (65.34%) (15.94%)
Free cash flow yield 0.22% (21.13%) 0.00%

Profitability

Metric ANIK CGC Drug Manufacturers Specialty & Generic median
Gross margin 62.16% 25.16% 53.51%
Operating margin (4.24%) (54.89%) 0.00%
Net margin (3.14%) (80.39%) (2.45%)
Free cash flow margin 0.47% (28.34%) 0.00%
Return on equity (2.66%) (40.14%) (0.80%)
Return on assets (2.04%) (23.54%) (1.67%)
Return on invested capital (3.24%) (17.19%) 0.00%

Growth

Metric ANIK CGC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 5.33% 7.80% 5.22%
EPS growth (last fiscal year) 80.16% 84.00% 42.91%
Revenue growth, 5-year CAGR (2.86%) (13.04%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANIK CGC Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.35 0.04
Current ratio 4.48 3.04 2.41
Net debt to EBITDA 10.80 1.09 1.01

Dividend

Metric ANIK CGC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ANIK CGC Drug Manufacturers Specialty & Generic median
Market cap 258.69m 283.50m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack